Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases

Annals of Clinical Biochemistry

Volumn 46, Issue 1, 2009, Pages 38-43

  Gu, Yanli ^a   Chen, Wenli ^b   Zhao, Yu ^a   Chen, Liyun ^a   Peng, Tao ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GOLGI PROTEIN 73; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER DISEASES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; YOUNG ADULT;

EID: 58149479603     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2008.008088     Document Type: Article

References (22)

1. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4
2. Marrero JA, Lok AS. Newer markers for hepatocellular carcinoma. Gastroenterology 2004;127(Suppl. 51):S113-9
3. Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000;249:53-65
4. Maitra A, Thuluvath PJ. GP73 and liver disease: a (Golgi) complex enigma. Am J Gastroenterol 2004;99:1096-8
5. Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 2005;43:1007-12
6. Schwegler EE, Cazares L, Steel LF, et al. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 2005;41:634-42
7. Iftikhar R, Kladney RD, Havlioglu N, et al. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 2004;99:1087-95
8. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002;35:1431-40
9. Kladney RD, Tollefson AE, Wold WS, Fimmel CJ. Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology 2002;301:236 -46
10. Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate withliver cancer in woodchucks and humans. Proc Natl Acad Sci USA 2005;102:779-84
11. Bachert C, Fimmel C, Linstedt AD. Endosomal trafficking and proprotein convertase cleavage of cis golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 2007;8:1415-23
12. Wright LM, Kreikemeier JT, Fimmel CJ. A concise review of serum markers for hepatocellular cancer. Cancer Detect Prev 2007;31:35-44
13. Harlow ELD. Using Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999
14. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7
15. Chinese Society of Hepatology. 2004 Guidelines for surgical treatment of primary hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2005;13:329-30
16. Chinese Society of Infectious Diseases. The guidelines of prevention and treatment for chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2005;13:881-91
17. Chinese Medical Association. Guideline of prevention and treatment of hepatitis C. Zhonghua Yu Fang Yi Xue Za Zhi 2004;38:210-5
18. DeForge LE, Shih DH, Kennedy D, et al. Species-dependent serum interference in a sandwich ELISA for Apo2L/TRAIL. J Immunol Methods 2007;320:58-69
19. Gull I, Wirth M, Gabor F. Development of a sensitive and reliable ELISA for quantification of wheat germ agglutinin. J Immunol Methods 2007;318:20-9
20. Wang Q, Chen Y, Xie F, et al. Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graveś disease. Cytokine 2006;36:23-8
21. Metz CEhB, Shen JH. Maximum-likelihood estimation of receiver operating characteristic (ROC) curves from continously distributed data. Stat Med 1998;17:1033-53
22. Puri S, Bachert C, Fimmel CJ, Linstedt AD. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 2002;3:641-53